高萍治疗乳腺癌内分泌综合征的中医诊疗经验

祁薇; 于冬冬; 关徐涛; 王涛; 王冰; 高萍

doi:10.13192/j.issn.1000-1719.2022.03.005

意见反馈

您当前的位置：

首页 >

文章列表页 >

高萍治疗乳腺癌内分泌综合征的中医诊疗经验

中国中医药临床案例成果库

上一篇: 田德禄教授对肝气证治的认识

下一篇: 祝肇刚从虚论治食管裂孔疝经验

高萍治疗乳腺癌内分泌综合征的中医诊疗经验
GAO Ping's Thoughts on Diagnosis and Treatment of Endocrine Syndrome of Breast Cancer
1.河南中医药大学第一附属医院，河南　郑州　450000
2.河南中医药大学，河南　郑州　450000
DOI：10.13192/j.issn.1000-1719.2022.03.005

扫描看全文

祁薇, 于冬冬, 关徐涛, 等. 高萍治疗乳腺癌内分泌综合征的中医诊疗经验[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2022.03.005

QI Wei, YU Dongdong, GUAN Xutao, et al. GAO Ping's Thoughts on Diagnosis and Treatment of Endocrine Syndrome of Breast Cancer[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2022.03.005
祁薇, 于冬冬, 关徐涛, 等. 高萍治疗乳腺癌内分泌综合征的中医诊疗经验[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2022.03.005 DOI：

QI Wei, YU Dongdong, GUAN Xutao, et al. GAO Ping's Thoughts on Diagnosis and Treatment of Endocrine Syndrome of Breast Cancer[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2022.03.005 DOI：

摘要

随着乳腺癌发病率逐年飙升以及对乳腺癌患者内分泌治疗研究的不断深入，内分泌治疗在激素受体阳性乳腺癌患者的临床治疗中地位不断提升。这些药物可有效控制肿瘤的病情进展，但也可引起一系列的内分泌综合征，这一不良反应严重影响了乳腺癌患者的生理、心理和社会交往能力，对患者的生存质量产生了严重的负面影响。以致于很多乳腺癌患者不得不放弃内分泌治疗，大大降低了乳腺癌患者内分泌治疗的依从性，导致疾病的复发转移。但目前西医对乳腺癌内分泌综合征并无很好的治疗手段，多为对症支持治疗，并未取得实质性的治疗进展，所以中医药可发挥其治疗优势，缓解乳腺癌内分泌综合征，提高患者生存治疗以及继续内分泌治疗的依赖性。河南中医药大学第一附属医院高萍教授认为乳腺癌内分泌综合征的主要病机是脾肾两虚为本，瘀毒内蕴为标，高老师在治疗乳腺癌内分泌综合征中坚持辨证与辨病相结合的原则，以补肾健脾为主，活血解毒为辅，并根据病人症状随症加减，临床疗效较好，故加以总结。

Abstract

With the increasing incidence of breast cancer and endocrine therapy for breast cancer patients, endocrine therapy has been improving the clinical treatment status of hormone receptor positive breast cancer patients. These drugs can effectively control the progress of tumor, but also cause a series of endocrine syndrome, which seriously affects the physiological, psychological and social communication ability of breast cancer patients, and has a serious negative impact on the quality of life of patients. As a result, many breast cancer patients have to give up endocrine therapy, which greatly reduces the compliance of endocrine therapy in breast cancer patients, leading to the recurrence and metastasis of the disease. But at present, western medicine has no good treatment for endocrine syndrome of breast cancer, most of which are symptomatic support treatment, and no substantial progress has been made. Therefore, traditional Chinese medicine can give full play to its therapeutic advantages, alleviate endocrine syndrome of breast cancer, improve the dependence of survival treatment and continuous endocrine treatment. Professor GAO Ping believes that the main pathogenesis of breast cancer endocrine syndrome is spleen and kidney deficiency, and blood stasis and toxin accumulation. In the treatment of breast cancer endocrine syndrome, Professor GAO adheres to the principle of combining syndrome differentiation with disease differentiation, focusing on tonifying kidney and spleen, supplemented by activating blood circulation and detoxification, and according to the patient's symptoms, the clinical effect is better. And so it is summarized.

关键词

高萍乳腺癌内分泌综合征诊疗思路

Keywords

GAO Pingbreast cancer endocrine syndromediagnosis and treatment ideas

references

BOUVIER ANNE-SOPHIE, PANCHBHAYA NABILAH, BROCHARD CAMILLE, et al. Uterine metastasis from invasive ductal breast carcinoma: A case report with literature review[J]. J Gynecol Obstet Hum Reprod, 2021, 50(1): 101993.

HENRY DEENA PRISCILLA, RANJAN JASMINE, MURUGAN RAJESH KUMAR, et al. Exploration of anti-breast cancer effects of Terminalia chebula extract on DMBA-induced mammary carcinoma in Sprague Dawley rats[J]. Future Journal of Pharmaceutical Sciences, 2020, 6(1): 1-13.

李丹娟, 陈玮, 周兴平, 等. 绝经后乳腺癌与血清性激素及胰岛素样生长因子的相关性研究[J]. 中国妇幼保健, 2020, 35(23): 4456-4458.

魏灿灿, 张永平, 寇真真, 等. 老年女性乳腺分泌型癌一例临床病理特征及文献复习[J]. 中国组织化学与细胞化学杂志, 2020, 29(4): 345-348.

盛英文, 徐冰. 乳腺癌的分子靶向治疗[J]. 医学理论与实践, 2020, 33(23): 3905-3907,3910.

毕晓艳. 扶正益气汤联合阿那曲唑药物治疗乳腺癌患者的临床效果研究[J]. 中国现代药物应用, 2020, 14(23): 229-231.

吴玉婷, ALEXANDER TOBIAS TEICHMANN, 吴斌, 等.2例HER-2阳性乳腺癌综合治疗的MDT讨论及反思[J]. 中国普外基础与临床杂志, 2021, 28(4): 500-507.

郑颖娟, 王辉, 刘晓静, 等. 人参皂苷对Luminal型乳腺癌中Fas、FasL表达水平的影响[J]. 辽宁中医杂志, 2020, 47(10): 185-189,226.

叶永娟.ER、PR、CerbB-2与乳腺癌超声图像表现的相关性研究[J]. 中国卫生标准管理, 2020, 11(22): 46-48.

ALEXANDRA SCHOOS, VANESSA M KNAB, CORDULA GABRIEL, et al. In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours[J]. Vetering and Comparative Oncology, 2019, 17(4): 507-521.

朱明玥, 吕志刚. 当代乳腺癌中医专家治疗乳腺癌术后并发症经验分析[J]. 南京中医药大学学报, 2020, 36(6): 888-891.

杨丽娜, 李天昊, 杨振江, 等. 中药内服预防三阴性乳腺癌术后复发转移临床及实验研究进展[J]. 新中医, 2020, 52(17): 17-21.

朱为康, 陈旻, 李雁, 等. 补肾疏肝联合芳香化酶抑制剂治疗绝经后激素受体阳性乳腺癌[J]. 世界中医药, 2020, 15(20): 3113-3116,3120.

张传雷, 郑玉玲. 丹栀逍遥散合二至丸治疗三苯氧胺不良反应的研究[J]. 中医学报, 2012, 27(1): 6-8.

梁聪, 李媛媛, 莫凡露, 等. 复方山慈菇醇提物对人乳腺癌MDAMB-231细胞增殖与凋亡的影响[J]. 广西医科大学学报, 2020, 37(4): 690-694.

解霞, 赵瑾瑶, 高清波, 等. 蝎毒对人乳腺癌MCF-7/ADM细胞多药耐药的影响及机制研究[J]. 大连医科大学学报, 2006(5): 376-377,383.

马春兰, 张宝亮, 张常虹. 莪术醇对乳腺癌细胞增殖凋亡及JAK2/STAT3信号通路的影响[J]. 肿瘤学杂志, 2020, 26(7): 616-620.

王信林, 宋歌, 王艳新, 等. 白花蛇舌草与半枝莲配伍对乳腺癌细胞MCF-7增殖的影响[J]. 泰山医学院学报, 2019, 40(1): 31-33.

杨瑷竹, 李然, 刘立萍. 基于“木郁达之”探讨疏肝健脾法对乳腺癌骨微环境的影响[J]. 中医学报, 2021, 36(2): 282-284.

祝利民, 张琦君, 郭玲建, 等. 乳岩宁方对绝经后乳腺癌内分泌治疗患者生活质量及免疫功能的影响[J]. 世界科学技术-中医药现代化, 2020, 22(12): 4352-4359.

李娟, 李杰. 从“少阳为枢”论治乳腺癌患者合并混合性焦虑抑郁障碍[J]. 世界中医药, 2021, 16(3): 487-490.

栗文菊. 中医情志护理对乳腺癌放疗患者负性情绪及应激反应的影响[J]. 新中医, 2021, 53(8): 139-141.

郭栴子, 朱中博, 杨硕等. 乳腺癌之情志论[J]. 辽宁中医杂志, 2020, 47(12): 71-73.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

高萍教授治疗慢性再生障碍性贫血经验